Evidence map›Paper›PMID 40473912›Full record

ArticleCommunications biology2025

Structural basis for target DNA cleavage and guide RNA processing by CRISPR-Casλ2.

Satoshi N Omura, Lauren E Alfonse, Alexa Ornstein, Hayato Morinaga, Hisato Hirano, Yuzuru Itoh, Gabrielle Munoz, Anthony J Garrity, Gregory R Hoffman, Tia DiTommaso and 5 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Satoshi N OmuraDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2436-0847
Lauren E AlfonseArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-6273-2168
Alexa OrnsteinArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
Hayato MorinagaDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Hisato HiranoDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Yuzuru ItohDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7802-5572
Gabrielle MunozArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
Anthony J GarrityArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
Gregory R HoffmanArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
Tia DiTommasoArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5309-300X
Winston X YanArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
David R ChengArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
David A ScottArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
Zachary MabenArbor Biotechnologies, 20 Acorn Park Drive, Tower 500, Cambridge, MA, USA.
Osamu NurekiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan. nureki@bs.s.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-1813-7008

Funding

Japan Agency for Medical Research and Development (AMED) JP23fa627001
6 · The paper itself

Abstract

RNA-guided CRISPR-Cas nucleases are widely used as versatile genome-engineering tools. Among the diverse CRISPR-Cas effectors, CRISPR-Casλ-also referred to as Cas12n-is a recently identified miniature type V nuclease encoded in phage genomes. Given its demonstrated nuclease activity in both mammalian and plant cells, Casλ has emerged as a promising candidate for genome-editing applications. However, the precise molecular mechanisms of Casλ family enzymes remain poorly understood. In this study, we report the identification and detailed biochemical and structural characterizations of CRISPR-Casλ2. The cryo-electron microscopy structures of Casλ2 in five different functional states unveiled the dynamic domain rearrangements during its activation. Our biochemical analyses indicated that Casλ2 processes its precursor crRNA to a mature crRNA using the RuvC active site through a unique ruler mechanism, in which Casλ2 defines the spacer length of the mature crRNA. Furthermore, structural comparisons of Casλ2 with Casλ1 and CasΦ highlighted the diversity and conservation of phage-encoded type V CRISPR-Cas enzymes. Collectively, our findings augment the mechanistic understanding of diverse CRISPR-Cas nucleases and establish a framework for rational engineering of the CRISPR-Casλ-based genome-editing platform.

Indexed as

CRISPR-Associated ProteinsCRISPR-Cas SystemsDNA CleavageRNA, Guide, CRISPR-Cas SystemsBacteriophagesCryoelectron MicroscopyGene EditingCRISPR-Associated ProteinsRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID40473912
PMCPMC12141684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.